Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
86.6M
-
Shares change
-
+1.22M
-
Total reported value, excl. options
-
$4.86B
-
Value change
-
+$56.7M
-
Put/Call ratio
-
0.51
-
Number of buys
-
104
-
Number of sells
-
-94
-
Price
-
$56.09
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q1 2024
248 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q1 2024.
Legend Biotech Corp - COMMON STOCK (LEGN) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.6M shares
of 367M outstanding shares and own 23.58% of the company stock.
Largest 10 shareholders include FMR LLC (16.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.9M shares), RA CAPITAL MANAGEMENT, L.P. (6.86M shares), HHLR ADVISORS, LTD. (5.98M shares), BlackRock Inc. (5.38M shares), WELLINGTON MANAGEMENT GROUP LLP (2.61M shares), Capital World Investors (2.39M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.24M shares), Capital International Investors (2.18M shares), and JANUS HENDERSON GROUP PLC (2.01M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.